Elisa Izquierdo Selected Research

Diffuse Intrinsic Pontine Glioma

1/2022

DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisa Izquierdo Research Topics

Disease

6	Neoplasms (Cancer) 10/2022 - 10/2017
2	Rhabdomyosarcoma 10/2022 - 01/2022
2	Glioma (Gliomas) 01/2021 - 01/2018
1	Diffuse Intrinsic Pontine Glioma 01/2022
1	Starvation 01/2022
1	Disease Progression 01/2021

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2019
2	Circulating Tumor DNAIBA 10/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2022
1	Culture MediaIBA 01/2022
1	infigratinibIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	nintedanibIBA 01/2022
1	ponatinibIBA 01/2022
1	dipinacoline glutamateIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	LigandsIBA 01/2022
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Histones (Histone)IBA 10/2017

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
1	Operative Surgical Procedures 01/2021
1	Precision Medicine 11/2019
1	Radiotherapy 01/2018